Ginkgo Bioworks is pivoting: Once a synthetic biology darling, the flailing company has now turned to AI-driven protein ...

Brendan Smith, an analyst from TD Cowen, maintained the Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report). The associated ...

Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $6.81 which represents a slight increase of $0.58 or 9.31% from the prior close of $6.23. The stock opened at $6.37 and ...